80% with one dose seems right in line with 75% with one dose of J&J (in the US). For what it's worth, J&J is also now doing a phase trial of two doses, and I ex

80% with one dose seems right in line with 75% with one dose of J&J (in the US). For what it's worth, J&J is also now doing a phase trial of two doses, and I expect that to be around 90% too. So yes, once you take into account the +/- 5% error, they seem to be pretty much equal.